Status:
UNKNOWN
Characteristics of Neonatal Covid-19 in Turkey
Lead Sponsor:
Recep Tayyip Erdogan University Training and Research Hospital
Collaborating Sponsors:
Turkish Neonatal Society
Conditions:
COVID-19
Neonatal Disease
Eligibility:
All Genders
Up to 28 years
Brief Summary
The investigators aimed to investigate the clinical and epidemiological characteristics of neonates who will be born to Covid-19 positive mothers in Turkey. It is a multicentric prospective cohort stu...
Detailed Description
The patients will be recruited by a secure database of "Trials Network" with individualized accounts. Plexus Corporation will hold data monitoring and primary analysis.
Eligibility Criteria
Inclusion
- Infants born to mothers with Covid-19 infection
Exclusion
- If PCR values of mother negative, even though the clinic is preferable for Covid-19, the infant will not be recruited.
Key Trial Info
Start Date :
May 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 30 2020
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT04401540
Start Date
May 1 2020
End Date
December 30 2020
Last Update
July 14 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Recep Tayyip Erdogan University Medical School
Rize, Turkey (Türkiye), 53200